Trial Profile
A Phase 2 Study to Assess the Efficacy and Safety of CMX-020 in Treating Osteoarthritis.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs CMX 020 (Primary) ; Celecoxib
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Cmxtwenty
- 17 Oct 2016 New trial record